Nationwide Fund Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-539
| Closed | -$223K | – | 180 |
|
|
2017
Q3 | $223K | Hold |
539
| – | – | ﹤0.01% | 2586 |
|
|
2017
Q2 | $189K | Hold |
539
| – | – | ﹤0.01% | 2643 |
|
|
2017
Q1 | $277K | Sell |
539
-32
| -6% | -$16.4K | ﹤0.01% | 2449 |
|
|
2016
Q4 | $203K | Sell |
571
-33
| -5% | -$11.7K | ﹤0.01% | 2589 |
|
|
2016
Q3 | $323K | Hold |
604
| – | – | ﹤0.01% | 2397 |
|
|
2016
Q2 | $340K | Buy |
604
+166
| +38% | +$93.4K | ﹤0.01% | 2355 |
|
|
2016
Q1 | $208K | Hold |
438
| – | – | ﹤0.01% | 2520 |
|
|
2015
Q4 | $289K | Buy |
438
+8
| +2% | +$5.28K | ﹤0.01% | 2372 |
|
|
2015
Q3 | $338K | Buy |
430
+55
| +15% | +$43.2K | ﹤0.01% | 2316 |
|
|
2015
Q2 | $494K | Buy |
375
+194
| +107% | +$256K | ﹤0.01% | 2254 |
|
|
2015
Q1 | $188K | Buy |
181
+13
| +8% | +$13.5K | ﹤0.01% | 2723 |
|
|
2014
Q4 | $112K | Buy |
+168
| New | +$112K | ﹤0.01% | 2877 |
|